Plenty of businesses met their new partners. Photo by Luis Alvarez/Getty

Earlier in August, participants from around the globe gathered online for HealthTech Beyond Borders, a virtual summit hosted by ProChile that's designed to match American and Chilean businesses looking to explore the future and impact of new technologies in the healthcare sector.

During the four-day event, registrants sat in on more than 65 meetings — or an average of 2.5 meetings per hour — that tackled such topics as "Why Chile? Exploring Chilean Medical Innovations," "Dynamic Growth for Healthcare Innovators/Innovations (Venture Capital)," and "Harnessing Healthcare's Regional Resources: Chicago, Houston, Philadelphia."

"I was really impressed by the quality of groups and speakers for this event," says Torrey Adams, senior director of global life sciences at Greater Houston Partnership. "It was a very well put together with excellent networking and connecting opportunities. I gained a much better insight on the possibilities of collaborating with Chilean companies."

There were 37 registrants from Texas, which also contributed such strategic partners as Houston Methodist Hospital, the City of Houston, Houston Exponential, The Cannon, Greater Houston Partnership, MediaTech Ventures, Central Houston Inc., and InnovationMap (hello!).

A total of 35 Chilean companies participated, with such heavy-hitters as Cens (the national center for healthcare systems), ChileTech (a health providers association), Apis (medical devices), and CNL (the national labs board) joining the roster.

"It was a pleasure to moderate the HealthTech Beyond Borders session," says José F. Núñez, vice president of global development at Houston Methodist Global Health Care Services. "It is forums like these that foster the exchange of ideas and bring together individuals and organizations to further promote innovation in the health sciences space. Kudos to ProChile, Chicago, Houston, and Philadelphia for the resources they provide to entrepreneurs in facilitating these connections."

Though it's impossible to know the actual numbers — ProChile isn't privy to private negotiations — a survey taken by the attending companies estimates that $1 million in immediate business will be done as a direct result of the event. In the next 12 months, that figure is estimated to jump up to $2.9 million.

"We created an inclusive 'village' of innovation where entrepreneurs and startups from around the world come to solve humankind's boldest challenges," says Robert Pieroni, director of economic development for Central Houston, Inc. "Events like ProChile's HeathTech Beyond Borders demonstrate how the world is responding to what Houston has built. With Downtown Launchpad, TMC Innovation, the Ion, and others, we are clearly becoming a global center of gravity to inspire innovation and support entrepreneurship."

Find your next global match. Photo by Tone Fotografia/Getty

Final call for virtual global healthtech summit — and it's free to attend

Get Your Tickets

It's nearly time: The online international summit HealthTech Beyond Borders is about to explore the future and impact of new technologies in the healthcare sector. A special focus on medical and healthcare developments and opportunities in Chicago, Houston, and Philadelphia is the highlight this year's event.

The basics
HealthTech Beyond Borders is sponsored by ProChile and runs August 10-13, with four days of virtual programming. You can reserve your spot for free here.

The topics
A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

The summits
There are three summits on the docket., each beginning at 9:55 am Central. Day one's focus is "Why Chile? Exploring Chilean Medical Inventions," while day two will cover "Dynamic Growth for Healthcare Innovators/Innovations." Day three's focus is "Harnessing Healthcare's Regional Resources: Chicago, Houston, Philadelphia."

The speakers
Panelists include Matias Gutierrez, CEO of Genosur LLC; Alberto Rodríguez Navarro from Levita Magnetics, and such Chilean organizations as Asocciación de Clínicas, Asociación de Proveedores de la Industria de la Salud, Associación Nano Cámara Nacional de Laboratorios, ChileTec, Cobre, and Hospital Fundación Lopez Perez.

From the United States, presenting organizations include MEDIATECH Ventures, Houston Methodist, MATTER Health, the Chilean & American Chamber of Commerce of Greater Philadelphia, City of Houston, City of Philadelphia, Greater Houston Partnership, The Cannon, World Business Chicago, and Widener University Small Business Development Council.

The stats
A whopping 13 percent of Chile's startups are healthcare related (according to the Science, Technology, Knowledge, and Innovation Ministry of Chile) and the growth rate of robotic surgeries done in Chile between 2010 and 2018 increased by 674 percent.

An estimated 93.7 percent of the Chilean population is covered by health insurance, and the county has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America.

Likewise, the United States is the top destination for Chilean exports of medical devices, representing over 25 percent of the total Chilean exports in the sector.

The Free Trade Agreement of 2004 and the Duty-Free status between the two countries also make Chile an attractive and reliable trade partner. So much so, that the U.S. is the No. 1 investor in Chile, with $22 billion invested in projects in the last 7 years.

You won't want to miss this virtual gathering — RSVP for free here.

Connect globally without ever leaving the States. Photo by Leo Patrizi/Getty

It's almost time for the free global healthtech event you won't want to miss

Reserve Your Spot

Imagine a gathering of such healthtech heavy-hitters as Genosur, Levita, MEDIATECH Ventures, Houston Methodist, and MATTER Health, all in one (virtual) room.

Now imagine hearing not only from these companies, but from a dozen more representing both America and Chile in a four-day online event, held August 10-13 that's free to attend.

HealthTech Beyond Borders, sponsored by ProChile, helps facilitate matchmaking opportunities between medical and healthcare organizations from both countries. Not only can they learn from one another, but hopefully these meetings will set the stage for future global collaborations.

The international summit will also explore the future and impact of new technologies in the healthcare sector. A special focus on medical and healthcare developments and opportunities in Chicago, Houston, and Philadelphia is the highlight this year's event.

"We are proud to produce this event and bring so many innovative and leading healthcare organizations and associations together," says Sylas Bailey-Kelly, Chilean Trade Commissioner US Midwest. "Medical and healthcare innovation is an area where Chile and the United States can excel and continue to collaborate to benefit citizens in both countries, and around the world."

As the top investor in Chile, with $22 billion devoted to Chilean projects in the last seven years, the United States is the largest stakeholder in Chilean business developments and the top destination for Chilean exports of medical devices.

Likewise, an estimated 93.7 percent of the population in Chile is covered by health insurance, and the country has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America. Chile currently spends nearly 9.14 percent of its GDP on health as compared to the United States, where we only spend 13 percent on healthcare.

Some helpful logistics about the event: Its matchmaking platform allows participants to customize meeting times to fit their own schedules. Attendees can pick and choose which days and times they want to attend and can have one-to-one meetings (25 minutes per meeting) with Chilean participants from research centers, universities, hospitals, healthcare solution providers, and other key Chilean institutions.

The schedule for panel discussions will be posted in advance of the meeting. Presentations on partnering with Chile and the economic opportunities available, along with conversations on geographic hot spots in the U.S. and access to capital, will also be topics highlighted throughout the event.

A more detailed list of the participants includes Chilean organizations Asocciación de Clínicas, Asociación de Proveedores de la Industria de la Salud, Associación Nano Cámara Nacional de Laboratorios, ChileTec, Cobre, and Hospital Fundación Lopez Perez. From the United States, presenting organizations include the Chilean & American Chamber of Commerce of Greater Philadelphia, City of Houston, City of Philadelphia, Greater Houston Partnership, The Cannon, World Business Chicago, and Widener University Small Business Development Council.

If your company develops and sells healthcare products and services, medical devices, and equipment, or is a hospital supply manufacturer, you should attend this unique event.

Registration for HealthTech Beyond Borders is free — reserve your spot now.

Connect globally for free. Photo by AJ Watt/Getty

Get a glimpse at the schedule and speakers for global healthtech event

Itinerary Time

HealthTech Beyond Borders is coming up August 10-13, 2021, where American healthtech companies can find their perfect match with Chilean collaborators. But what exactly can you expect from the free, virtual event?

Besides answering the question "why Chile?," the seminars will touch on everything from software solutions and medical facility management to healthcare products and services, and even venture capital opportunities.

A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

The first day includes such panelists as Matias Gutierrez, CEO of Genosur LLC, and Alberto Rodríguez Navarro from Levita Magnetics.

A discussion on the current healthcare innovation ecosystem in Chile and the region's strengths, as well as developments for key sub-sectors are also on tap.

Day two kicks off with everything you'd want to know about venture capital, and why the U.S. has been the largest for Chilean startups.

Find answers to questions like what do early stage companies need to consider and what steps do they need to take to best prepare themselves to receive funding, as well as what are the important tools for companies to reach VC on each territory?

Day three examines the question "Why the U.S.?" What have Houston, Chicago, and Philadelphia done to become key healthcare hubs in the world, and what role do international partners play in these efforts? Representatives from each city are participating.

Likewise, why do international healthcare companies prioritize your respective markets, and how do these cities support expansion? Learn how the global U.S. private healthcare sector can reach Latin America, and how ProChile — the event's sponsor — can help make these connections.

Registration is now open, so get your free tickets here.

Great collaboration doesn't abide by borders. Photo by Blue Images/Getty

Free virtual event helps healthtech companies go global

Matchmaker, Matchmaker

In the growing healthtech sector, two is better than one — two partners, that is. If you've ever been curious what collaborating with an international company would be like, HealthTech Beyond Borders can provide answers.

The free virtual event, sponsored by ProChile and set for August 10-13, 2021, was created to offer matchmaking opportunities and set the scene for global collaborations focused on innovative medical technology between companies from Chile and the United States.

A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

You can explore everything from software solutions and medical facility management to healthcare products and services, and even venture capital opportunities.

And if you're wondering "why Chile?" there are some pretty compelling stats.

A whopping 13 percent of Chile's startups are healthcare related (according to the Science, Technology, Knowledge, and Innovation Ministry of Chile) and the growth rate of robotic surgeries done in Chile between 2010 and 2018 increased by 674 percent.

An estimated 93.7 percent of the Chilean population is covered by health insurance, and the county has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America.

Likewise, the United States is the top destination for Chilean exports of medical devices, representing over 25 percent of the total Chilean exports in the sector.

The Free Trade Agreement of 2004 and the Duty-Free status between the two countries also make Chile an attractive and reliable trade partner. So much so, that the U.S. is the No. 1 investor in Chile, with $22 billion invested in projects in the last 7 years.

And with Houston being home to the largest hospital center in the world — Texas Medical Center, which served 13 million patients in 2020 — it only makes sense that healthtech companies here would be looking for ways to improve and expand. Reserve your free spot for the event here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.